Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea · Delayed Price · Currency is KRW 3,050.00
-30.00 (-0.97%)
At close: Sep 17, 2025
Precision Biosensor Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 19,361 | 19,134 | 20,391 | 20,458 | 15,887 | 8,685 | Upgrade |
Other Revenue | -0 | -0 | - | - | -0 | - | Upgrade |
| 19,361 | 19,134 | 20,391 | 20,458 | 15,887 | 8,685 | Upgrade | |
Revenue Growth (YoY) | 12.99% | -6.17% | -0.33% | 28.77% | 82.93% | 39.97% | Upgrade |
Cost of Revenue | 13,222 | 12,952 | 12,705 | 13,703 | 11,282 | 3,918 | Upgrade |
Gross Profit | 6,139 | 6,182 | 7,686 | 6,755 | 4,605 | 4,767 | Upgrade |
Selling, General & Admin | 6,675 | 6,406 | 7,288 | 7,437 | 6,303 | 3,783 | Upgrade |
Research & Development | 3,065 | 3,586 | 3,196 | 2,611 | 1,958 | 2,045 | Upgrade |
Other Operating Expenses | 395.07 | 363.88 | 249.05 | 231.68 | 243.58 | 230.47 | Upgrade |
Operating Expenses | 11,297 | 11,549 | 12,496 | 11,255 | 8,874 | 6,485 | Upgrade |
Operating Income | -5,158 | -5,366 | -4,811 | -4,500 | -4,269 | -1,719 | Upgrade |
Interest Expense | -2,049 | -1,991 | -1,230 | -816.95 | -162.1 | -23.57 | Upgrade |
Interest & Investment Income | 121.04 | 164.95 | 188.19 | 187.26 | 70.52 | 71.82 | Upgrade |
Currency Exchange Gain (Loss) | -141.5 | 577.46 | 196.85 | 254.17 | 285.95 | -142.3 | Upgrade |
Other Non Operating Income (Expenses) | -1,170 | -709.87 | -172.23 | -2,273 | -254.15 | -2,997 | Upgrade |
EBT Excluding Unusual Items | -8,398 | -7,324 | -5,827 | -7,148 | -4,329 | -4,810 | Upgrade |
Gain (Loss) on Sale of Investments | 17.23 | 33.36 | 90.06 | 137.79 | 48.66 | - | Upgrade |
Gain (Loss) on Sale of Assets | 3.58 | 3.01 | - | 5.27 | 0.03 | -142.71 | Upgrade |
Other Unusual Items | - | 319.15 | 354.95 | - | - | - | Upgrade |
Pretax Income | -8,377 | -6,969 | -5,382 | -7,005 | -4,281 | -4,953 | Upgrade |
Income Tax Expense | 527.83 | 336.5 | -892.03 | -199.36 | -128.31 | 0.3 | Upgrade |
Net Income | -8,905 | -7,305 | -4,490 | -6,806 | -4,152 | -4,953 | Upgrade |
Net Income to Common | -8,905 | -7,305 | -4,490 | -6,806 | -4,152 | -4,953 | Upgrade |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 11 | 9 | Upgrade |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 11 | 9 | Upgrade |
Shares Change (YoY) | - | 0.09% | 0.67% | 2.10% | 25.37% | 24.75% | Upgrade |
EPS (Basic) | -766.72 | -628.96 | -386.98 | -590.47 | -367.80 | -550.04 | Upgrade |
EPS (Diluted) | -767.00 | -629.00 | -387.00 | -590.47 | -368.00 | -550.04 | Upgrade |
Free Cash Flow | -2,069 | -1,509 | -9,006 | -13,719 | -13,726 | -6,950 | Upgrade |
Free Cash Flow Per Share | -178.14 | -129.92 | -776.13 | -1190.18 | -1215.81 | -771.85 | Upgrade |
Gross Margin | 31.71% | 32.31% | 37.69% | 33.02% | 28.98% | 54.89% | Upgrade |
Operating Margin | -26.64% | -28.04% | -23.59% | -22.00% | -26.87% | -19.79% | Upgrade |
Profit Margin | -45.99% | -38.18% | -22.02% | -33.27% | -26.14% | -57.03% | Upgrade |
Free Cash Flow Margin | -10.69% | -7.89% | -44.17% | -67.06% | -86.40% | -80.03% | Upgrade |
EBITDA | -1,285 | -1,777 | -1,665 | -2,218 | -3,091 | -948.01 | Upgrade |
EBITDA Margin | -6.64% | -9.29% | -8.17% | -10.84% | -19.45% | -10.91% | Upgrade |
D&A For EBITDA | 3,873 | 3,590 | 3,145 | 2,282 | 1,179 | 770.51 | Upgrade |
EBIT | -5,158 | -5,366 | -4,811 | -4,500 | -4,269 | -1,719 | Upgrade |
EBIT Margin | -26.64% | -28.04% | -23.59% | -22.00% | -26.87% | -19.79% | Upgrade |
Advertising Expenses | - | 114.04 | 200 | 76.59 | 108.79 | 30.48 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.